Form D · Other Health Care
Piraeus Medical, Inc.
Rochester, MN · CIK 0001933134
Offering snapshot reported Oct 7, 2026 · SEC filing
- Reported sold
- $10.5M Offering amount: $12M
- Investors reported
- 25 Form D · investor count
- Minimum accepted
- $1K Reported outside-investor minimum
- First sale
- Mar 31, 2026 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$3,575,100 → $10,525,100
- Reported investors11 → 25
- Minimum accepted$0 → $1,000
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 7, 2026 | Amendment | $10,525,100 | $6,950,000vs Apr 2, 2026 | 25 | SEC filing |
| Apr 2, 2026 | Initial | $3,575,100 | No comparison | 11 | SEC filing |
| Nov 5, 2025 | Initial | $662,600 | No comparison | 4 | SEC filing |
| Sep 22, 2025 | Initial | $300,000 | No comparison | 1 | SEC filing |
| Feb 19, 2025 | Initial | $2,000,001 | No comparison | 65 | SEC filing |
| Jul 23, 2024 | Initial | $6,000,000 | No comparison | 79 | SEC filing |
| Apr 4, 2024 | Amendment | $450,000 | $0vs Jul 3, 2023 | 5 | SEC filing |
| Aug 9, 2023 | Initial | $3,108 | No comparison | 2 | SEC filing |
| Jul 3, 2023 | Initial | $450,000 | No comparison | 5 | SEC filing |
| Dec 9, 2022 | Initial | $150,000 | No comparison | 2 | SEC filing |
| Jun 16, 2022 | Initial | $900,000 | No comparison | 13 | SEC filing |
| Jun 9, 2022 | Initial | $62,500 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-578832
Shares of Issuer Preferred Stock and the shares of capital stock of Issuer into which such shares of Preferred Stock may convert.
Source: Form D, filed Oct 7, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Martin Omid Akhavan | Director |
| Ryan Egeland | Director |
| Jared Hutar | Director, Executive |
| Kevin Kallmes | Director |
| Keith Kallmes | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
7351 Kirkwood Ln., Suite 104
Rochester, MN, 55369
Rochester, MN, 55369